Evaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imaging

被引：1
|
作者：
Mohamed Bouattour [1 ]
Audrey Payancé [1 ]
Johanna Wassermann [2 ]
机构：
[1] Department of Hepatology, Beaujon University Hospital (AP-HP - Paris 7 Diderot)
[2] Department of Medical Oncology, La Pitié-Salpêtrière University Hospital (AP-HP - Paris 6 Pierre et Marie Curie)
来源：
World Journal of Hepatology | 2015年 / 7卷 / 20期
关键词：
Hepatocellular carcinoma; Antiangiogenic therapies; Sorafenib; Predictive biomarkers; Prognosis biomarkers; Functional imaging;
D O I：
暂无
中图分类号：
R735.7 [肝肿瘤];
学科分类号：
100214 ;
摘要：
Many years after therapeutic wilderness, sorafenib finally showed a clinical benefit in patients with advanced hepatocellular carcinoma. After the primary general enthusiasm worldwide, some disappointments emerged particularly since no new treatment could exceed or at least match sorafenib in this setting. Without these new drugs, research focused on optimi-zing care of patients treated with sorafenib. One challenging research approach deals with identifying prognostic and predictive biomarkers of sorafenib in this population. The task still seems difficult; however appropriate investigations could resolve this dilemma, as observed for some malignancies where other drugs were used.
引用
下载
收藏
页码：2245 / 2263
页数：19
相关论文
共 50 条
  • [31] POTENTIAL BIOMARKERS OF SORAFENIB THERAPY IN ADVANCED HEPATOCELLULAR CARCINOMA
    Negri, Francesca V.
    Dal Bello, Barbara
    Campanini, Nicoletta
    Rossi, Sandro
    Porta, Camillo
    Tinelli, Carmine
    Poggi, Guido
    Missale, Gabriele
    Bisagni, Giancarlo
    Ardizzoni, Andrea
    Silini, Enrico M.
    ANNALS OF ONCOLOGY, 2011, 22 : v20 - v20
  • [32] SAFETY AND EFFICACY OF SORAFENIB FOR ADVANCED HEPATOCELLULAR CARCINOMA
    Sacco, P. C.
    De Sanctis, R.
    Quadrini, S.
    Gori, B.
    Del, Signore E.
    Stumbo, L.
    Tedeschi, M.
    Falbo, P. T.
    Fulvi, A.
    Grassi, P.
    Sollami, R.
    Basile, M. L.
    Di Seri, M.
    ANNALS OF ONCOLOGY, 2009, 20
  • [33] Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma
    Miyazaki, Masayuki
    Yada, Masayoshi
    Tanaka, Kosuke
    Senjyu, Takeshi
    Goya, Takeshi
    Motomura, Kenta
    Kohjima, Motoyuki
    Kato, Masaki
    Masumoto, Akihide
    Kotoh, Kazuhiro
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (29) : 5379 - 5385
  • [34] Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma
    Masayuki Miyazaki
    Masayoshi Yada
    Kosuke Tanaka
    Takeshi Senjyu
    Takeshi Goya
    Kenta Motomura
    Motoyuki Kohjima
    Masaki Kato
    Akihide Masumoto
    Kazuhiro Kotoh
    World Journal of Gastroenterology, 2017, (29) : 5379 - 5385
  • [35] Early Alpha-Fetoprotein Response Predicts Treatment Efficacy of Antiangiogenic Systemic Therapy in Patients With Advanced Hepatocellular Carcinoma
    Shao, Yu-Yun
    Lin, Zhong-Zhe
    Hsu, Chiun
    Shen, Ying-Chun
    Hsu, Chih-Hung
    Cheng, Ann-Lii
    CANCER, 2010, 116 (19) : 4590 - 4596
  • [36] IL-17 NEUTRALIZATION AMELIORATES THE EFFICACY OF ANTIANGIOGENIC TREATMENTS OF HEPATOCELLULAR CARCINOMA
    Rodrigues, Aurelie
    Machou, Camilia
    Calderaro, Julien
    Brouillet, Arthur
    Tijeras-Raballand, Annemilai
    Cong Trung Nguyen
    Rousseau, Benoit
    Pawlotsky, Jean-Michel
    Luciani, Alain
    Lafdil, Fouad
    HEPATOLOGY, 2019, 70 : 812A - 812A
  • [37] Antiangiogenic treatment in patients with hepatocellular carcinoma
    Krzemieniecki, Krzysztof
    ONCOLOGY IN CLINICAL PRACTICE, 2009, 5 : A44 - A47
  • [38] Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma
    Pang, Roberta
    Poon, Ronnie T. P.
    CANCER LETTERS, 2006, 242 (02) : 151 - 167
  • [39] Intermediate and advanced hepatocellular carcinoma treated with the antiangiogenic agent sorafenib. Evaluation with unenhanced and contrast-enhanced ultrasonography
    Moschouris, Hippocrates
    Malagari, Katerina
    Gkoutzios, Panagiotis
    Kalokairinou, Marianna
    Stamatiou, Konstantinos
    Chatzimichail, Katerina
    Kornezos, Ioannis
    Karagiannis, Evagelos
    Kiltenis, Michail
    Papadaki, Marina Georgiou
    MEDICAL ULTRASONOGRAPHY, 2012, 14 (02) : 87 - 94
  • [40] Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
    Llovet, Josep M.
    Pena, Carol E. A.
    Lathia, Chetan D.
    Shan, Michael
    Meinhardt, Gerold
    Bruix, Jordi
    CLINICAL CANCER RESEARCH, 2012, 18 (08) : 2290 - 2300
12345